Parkinson Platform Noord Nederland

As the movement disorder community enters the 50th anniversary since Birkmayer and Hornykiewicz first documented the clinical benefit of levodopa in patients with Parkinson's disease, it reflects on the advances in the treatment of the disease from the past half century and looks ahead to the developments that are likely to have a substantial effect on the specialty.